2 enrolling by invitation, 2 recruiting, 1 completed. 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Enrolling by invitation 1 |
Follow Blau syndrome: new trials by email Literature Review of Blau syndrome trials Research Report on Blau syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Tofacitinib in Refractory Blau Syndrome Janus Kinase Inhibitor - Blau Syndrome | Phase 4 | Enrolling by invitation | Peking Union Medical College Hospital | 30 | 2024-10-01 | 2024-10-28 |
| Phase 1 Study to Investigate OD-07656 in Healthy Adult Participants OD-07656 - Inflammatory Bowel Diseases, Blau Syndrome | Phase 1 | Completed | Odyssey Therapeutics, Inc. | 101 | 2024-02-12 | 2025-02-21 |
| Effective Treatment of Jak1/3 Inhibitor in Blau Syndrome Tofacitinib - Blau Syndrome | Enrolling by invitation | Tongji Hospital | 24 | 2017-01-01 | 2026-01-27 | |
| Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford Rare Disorders, Undiagnosed Disorders | Recruiting | Sanford Health | 20000 | 2010-07-01 | 2026-10-28 | |
| Immune Regulation in Patients With Common Variable Immunodeficiency and Related Inborn Errors of Immunity (IEI) XLA, CVID | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 500 | 1990-01-15 | 2026-10-29 |
3-Methylglutaconic Aciduria, Type V (1) · Achalasia Addisonianism Alacrimia syndrome (1) · Acrodysostosis (1) · Activated PI3K-delta Syndrome (1) · Addison Disease (1) · Agammaglobulinemia (1) · Alagille Syndrome (1) · Alstrom Syndrome (1) · Amnesia, Transient Global (1) · Aniridia (1) · Aniridia and Absent Patella (1) · Aniridia, Partial, with Unilateral Renal Agenesis and Psychomotor Retardation (1) · Ataxia (1) · Ataxia Neuropathy Spectrum (1)
Bone Diseases (2) · Colonic Diseases (2) · Digestive System Diseases (2) · Gastrointestinal Diseases (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunologic Deficiency Syndromes (2) · Intestinal Diseases (2) · Lymphatic Diseases (2) · Musculoskeletal Diseases (2) · Spinal Diseases (2) · Abnormalities, Multiple (1) · Adrenal Gland Diseases (1) · Adrenal Insufficiency (1)
Janus Kinase Inhibitors (1) · tofacitinib (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1) · Odyssey Therapeutics, Inc. (1) · Peking Union Medical College Hospital (1) · Sanford Health (1) · Tongji Hospital (1)
China (2) · United States (2) · Australia (1)
Anthony Opipari, MD, PhD (1) · Warren Strober, M.D. (1)